CLASS III Drug recall · Reported 24 Oct 2012 · FDA Enforcement Report

Children's Cetirizine HCl Chewable Tablets 5 mg recalled

Sandoz is recalling Children's Cetirizine HCl Chewable Tablets 5 mg, distributed nationwide in the US. The recall was initiated on 20 Sep 2012 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesNDC 0781-5283-64 lots: BT2862, BT7986, BT7994, BW0652, CC1961, and CA3437; NDC 0904-5878-33 lot BW0665.
NDC0781-5283
Quantity recalled67,937 x 30 tablet cartons; 24,640 x 5 tablet cartons

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-008-2013
FDA event ID
63224
Recalling firm
Sandoz, Broomfield, CO
Manufacturer
Sandoz Inc
Classification
Class III
Status
Terminated
Recall initiated
20 Sep 2012
FDA classified
18 Oct 2012
Reported
24 Oct 2012
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

20 Sep 2012Recall initiated by company
18 Oct 2012Classified by FDA+28 days
24 Oct 2012Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Impurity/Degradation; exceeded impurity specification at the 8 and 15 month time points (betacyclodextrin ester 1&2)

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Children's Cetirizine HCl Chewable Tablets 5 mg, 30 count blister pack, Manufactured in India by Sandoz Private Ltd., for Sandoz Inc., Princeton, NJ NDC 0781-5283-64 --- ALSO sold under Major brand All Day Allergy Children's Cetirizine HCl 5 mg, 5 count blister pack, Major Pharmaceuticals, Livonia, MI NDC 0904-5878-33

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Impurity/Degradation; exceeded impurity specification at the 8 and 15 month time points (betacyclodextrin ester 1&2)

Which lots are affected?

NDC 0781-5283-64 lots: BT2862, BT7986, BT7994, BW0652, CC1961, and CA3437; NDC 0904-5878-33 lot BW0665.

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Sandoz

All 59

Other Cetirizine recalls

All 18